Not applicableStudy completedNCT07607392
What this trial is testing
JAK2V617F Mutated Endothelium Has a Stem Cell Potential in Primary Myelofibrosis: a New Disease Ontogenesis for Chronic Myeloproliferative Disorders
Who this might be right for
Primary Myelofibrosids
Fondazione IRCCS Policlinico San Matteo di Pavia 30